Northern Trust’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$463K Sell
1,408,960
-7,580
-0.5% -$11.9K ﹤0.01% 3643
2025
Q4
$4.39M Sell
1,416,540
-78,863
-5% -$225K ﹤0.01% 2548
2025
Q3
$3.93M Sell
1,495,403
-24,723
-2% -$54.5K ﹤0.01% 2641
2025
Q2
$1.87M Buy
1,520,126
+1,110,010
+271% +$1.21M ﹤0.01% 3028
2025
Q1
$451K Sell
410,116
-1,210
-0.3% -$1.4K ﹤0.01% 3617
2024
Q4
$372K Buy
411,326
+626
+0.2% +$536 ﹤0.01% 3758
2024
Q3
$405K Sell
410,700
-30,315
-7% -$29.2K ﹤0.01% 3640
2024
Q2
$397K Buy
441,015
+54,457
+14% +$40.7K ﹤0.01% 3593
2024
Q1
$456K Sell
386,558
-56,228
-13% -$61.9K ﹤0.01% 3589
2023
Q4
$404K Buy
442,786
+6,026
+1% +$4.45K ﹤0.01% 3612
2023
Q3
$364K Buy
436,760
+240,395
+122% +$277K ﹤0.01% 3602
2023
Q2
$236K Sell
196,365
-412,469
-68% -$514K ﹤0.01% 3761
2023
Q1
$767K Sell
608,834
-50,853
-8% -$97.3K ﹤0.01% 3308
2022
Q4
$1.43M Sell
659,687
-14,284
-2% -$118K ﹤0.01% 3147
2022
Q3
$8.07M Buy
673,971
+46,896
+7% +$582K ﹤0.01% 2143
2022
Q2
$5.25M Buy
627,075
+34,900
+6% +$270K ﹤0.01% 2479
2022
Q1
$5.14M Sell
592,175
-5,914
-1% -$57K ﹤0.01% 2572
2021
Q4
$6.76M Sell
598,089
-2,348
-0.4% -$27.9K ﹤0.01% 2514
2021
Q3
$7.55M Sell
600,437
-7,769
-1% -$71.5K ﹤0.01% 2472
2021
Q2
$4.94M Buy
608,206
+5,066
+0.8% +$43.9K ﹤0.01% 2846
2021
Q1
$5.58M Sell
603,140
-51,796
-8% -$522K ﹤0.01% 2679
2020
Q4
$6.33M Sell
654,936
-22,613
-3% -$223K ﹤0.01% 2538
2020
Q3
$8.41M Buy
677,549
+33,600
+5% +$445K ﹤0.01% 2207
2020
Q2
$8.37M Buy
643,949
+124,731
+24% +$1.57M ﹤0.01% 2210
2020
Q1
$5.27M Sell
519,218
-472
-0.1% -$6.16K ﹤0.01% 2274
2019
Q4
$8.12M Buy
519,690
+11,086
+2% +$223K ﹤0.01% 2314
2019
Q3
$8.54M Buy
508,604
+328,788
+183% +$6.54M ﹤0.01% 2245
2019
Q2
$3.99M Buy
179,816
+16,340
+10% +$313K ﹤0.01% 2675
2019
Q1
$3.54M Buy
+163,476
New +$3.41M ﹤0.01% 2753

Other funds holding GOSS